Guru Ownership Trend
Guru Analysis for Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. (AUPH), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $47.15 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $8.15 M net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 97.1%. Conversely, John Hussman reduced exposure by 20.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Aurinia Pharmaceuticals Inc. (AUPH)
Major holders include Renaissance Technologies (RenTech) ($24.66 M), Cliff Asness ($14.06 M), Joel Greenblatt ($2.5 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 3.01 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $8.15 M, with 3 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited AUPH. The total reported sell value was $482,687.45.
Yes, 0 managers opened new positions in AUPH, and 3 increased their existing holdings. The total reported buy value was $8.63 M.
